FHB
First Hawaiian, Inc.
FHB's fundamentals are mixed: revenue grew 7.7%, but its operating margin fell 3 points to 36%. At 11x earnings, it's trading below its usual 13x. Analysts expect earnings growth, though they disagree widely on how much.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
FHB Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
FHB's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like FHB.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
FHB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 10x | $22.79 | -7.6% |
| Forward | 10x | $24.67 | — |
| Current | 11x | $24.67 | — |
| Fair | 13x | $28.33 | +15% |
| Expensive | 14x | $31.75 | +29% |
Historical ranges are pointers, not guarantees.
FHB's PE is in its cheap range at 11x. If earnings grow as analysts expect, today's price would be 10x next year's earnings.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
FHB Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for FHB, but weaker profitability. However, they disagree widely on these estimates.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
FHB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.42 | +8.7% |
| Q3 2026 | $2.23 | +8.8% |
| Q2 2026 | $2.30 | +19% |
| Q1 2026 | $2.28 | +24% |
| Q4 2025 | $2.20 | +23% |
| Q3 2025 | $2.05 | +17% |
| Q2 2025 | $1.94 | +12% |
| Q1 2025 | $1.84 | +5.7% |
| Q4 2024 | $1.79 | -2.7% |
FHB has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
FHB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $230.2M | +1.7% |
| Q2 2026 | $231.3M | +6.3% |
| Q1 2026 | $220.3M | +4.4% |
| Q4 2025 | $225.9M | +20% |
| Q3 2025 | $226.4M | +7.8% |
| Q2 2025 | $217.5M | +6.3% |
| Q1 2025 | $211M | +2.5% |
| Q4 2024 | $188.1M | -10% |
FHB's revenue has grown year over year for seven quarters in a row: $230M last quarter, up 1.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 22% | -21 points |
| Q2 2026 | 41% | +0.7 points |
| Q1 2026 | 40% | +3.2 points |
| Q4 2025 | 41% | +6.8 points |
| Q3 2025 | 42% | +6.1 points |
| Q2 2025 | 41% | +1 points |
| Q1 2025 | 36% | +2.1 points |
| Q4 2024 | 34% | +4.7 points |
FHB has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
FHB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $101.8M | +106% |
| Q2 2026 | $7.7M | -94% |
| Q1 2026 | $155.4M | +443% |
| Q4 2025 | $100M | -2.4% |
| Q3 2025 | $49.5M | -5.3% |
| Q2 2025 | $125.2M | +73% |
| Q1 2025 | $28.6M | -54% |
| Q4 2024 | $102.5M | +206% |
FHB has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
FHB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +139K shares |
| 1 year | -2% | -2.5M shares |
| 3 years | -4.3% | -5.5M shares |
| 5 years | -5.2% | -6.7M shares |
| Available history | -8.2% | -10.9M shares |
FHB has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $32M |
| Q4 2025 | $26M |
| Q3 2025 | $24M |
| Q2 2025 | $25M |
| Q1 2025 | $25M |
| Q4 2022 | — |
FHB spent $58M buying back its own shares over the past year.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
FHB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.7x | Net Cash |
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | -0.6x | Net Cash |
| Q4 2025 | -0.6x | Net Cash |
| Q3 2025 | -0.7x | Net Cash |
| Q2 2025 | -0.2x | Net Cash |
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
FHB has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like FHB.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
FHB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.9 | Neutral |
| Stochastic | 20.0 | Neutral |
FHB's weekly RSI is 38 (neutral) and its Stochastic is 20 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
FHB PE vs Financial Services Sector
| Metric | FHB | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 15% below |
| PE % | 23 | 63 | 40 pts below |
FHB is trading at 11x earnings, a 15% discount to the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
FHB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $25.0 | 1.5% below |
| 20 week MA | $26.5 | 7% below |
| 50 week MA | $26.4 | 6.7% below |
| 100 week MA | $25.6 | 3.7% below |
| 200 week MA | $23.6 | 4.5% above |
FHB has fallen below most of its moving averages, though it's still 4.5% above its 200-week average.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
FHB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.9 | $23.2 | -20% |
| 2021 | $23.2 | $26.9 | +16% |
| 2022 | $26.9 | $25.5 | -5.1% |
| 2023 | $25.5 | $22.9 | -10% |
| 2024 | $22.9 | $26.0 | +14% |
| 2025 | $26.0 | $26.1 | +0.4% |
| 2026 YTD | $26.1 | $24.7 | -5.3% |
FHB has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.